Skip to content

Canine-Assisted Anxiety Reduction In Emergency Care

Canine-Assisted Anxiety Reduction In Emergency Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03784573
Acronym
CANINE III
Enrollment
80
Registered
2018-12-24
Start date
2019-01-07
Completion date
2024-06-30
Last updated
2024-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Children, Opioid Use, Therapy Dog

Brief summary

Compare the effect of a single exposure to a therapy dog and handler within the pediatric emergency department patient with anxiety by measuring the change in patient perception of anxiety before and after dog exposure using the FACES scale. We will also measure galvanic skin response (resistance to electrical current).

Detailed description

This study challenges current dogma by introducing a widely available, low cost method of dog therapy to reduce patient stress. The organization Paws of Love estimates that it has 180,000 volunteers who have qualified therapy dogs and who are generally willing to volunteer their time in emergency care. The benefits may include improved perception of wellness, less opioid use, and decreased use of physical and chemical restraints. As a further extrapolation, this secondary effect may extend to improved patient-doctor communication and patient experience. This will in turn improve patient safety in the Emergency Department, decreasing the number of adverse events, and decreasing the risk of medical malpractice by improving the patient-provider relationship. (6, 7)

Interventions

BEHAVIORALDog + handler

Dog + handler

BEHAVIORALNo dog

No dog

Sponsors

Indiana University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Subjects will be randomized per dog and handler availability, but subjects that are excluded due to an aversion or dogs or per the Child Life staff member, can be in the control group.

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* 4-17 years old; * Physician or nurse with primary care responsibilities believes that the patients has a moderate to high level of anxiety

Exclusion criteria

\- violent behavior and any reported prior fear or adverse reaction to dogs in the dog intervention group.

Design outcomes

Primary

MeasureTime frameDescription
Change in anxiety level of subject45 minutesChange in anxiety level of subject with the use of the FACES scale

Secondary

MeasureTime frameDescription
Perception of pain level from parent(s)60 minutesChange in perception of pain level of subject by the parent(s) with the use of a Wong-Baker Faces pain scale
Meds4 hoursNumber of medications used to reduce anxiety in the different arms
Physical restrain use4 hoursNumber of times physical restraints are used
Perception of pain level from physician60 minutesChange in perception of pain level of subject with the use of a Wong-Baker Faces pain scale
Perception of anxiety level from parent(s)60 minutesChange in perception of anxiety level of subject by their parent(s) with the use of the FACES scale
Perception of anxiety level from physician60 minutesChange in perception anxiety level of subject with the use of the FACES scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026